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Introduction
Acute lymphocytic leukemia (ALL) is the most
commonly diagnosed pediatric cancer in the
United States (American Cancer Society 2005;
Linet et al. 1999; Sandler and Ross 1997).
Established risk factors such as ionizing radia-
tion and prenatal exposure to volatile organic
compounds (VOCs) do not explain most ALL
diagnoses (Belson et al. 2006; Greaves 1997;
Linet and Cartwright 1996). For the most part,
clustering of children diagnosed with ALL has
been attributed to chance (Boyle et al. 1996;
Caldwell 1990; Caldwell and Heath 1976).
However, when a county of 26,000 people
incurred more than a dozen leukemia diagnoses
during a 4-year period in which fewer than two
cases were expected, an investigation seemed
warranted [Nevada State Health Division
(NSHD) 2001; Steinmaus et al. 2004).
Potential environmental exposures. The
city of Fallon (population 8,000) is the only
urban center in Churchill County, Nevada.
The Naval Air Station–Fallon (NAS Fallon)
contributes an additional 3,000 residents to the
city’s population. The local community identi-
ﬁed four major areas of concern related to envi-
ronmental exposures. A pipeline runs through
downtown Fallon, delivering a continuous sup-
ply of JP-8 jet fuel to the base. Both municipal
and NAS water supplies have historically
reported naturally occurring arsenic levels that
exceed U.S. Environmental Protection Agency
(U.S. EPA) standards (Welch and Lico 1998;
Welch et al. 1989). Fallon is also a center for
melon and alfalfa production, and agricultural
pesticides are applied to ﬁelds surrounding the
city. Two facilities related to tungsten reﬁning
and use are located in Churchill County: An
administrative center and laboratory are in
downtown Fallon, and a tungsten carbide pro-
cessing plant is 11 miles north of Fallon
[Agency for Toxic Substances and Disease
Registry (ATSDR) 2003].
Initial identiﬁcation of the cluster. In July
2000, an astute local health care provider noti-
ﬁed state health ofﬁcials that several Churchill
County children had recently been diagnosed
with leukemia. In general, state cancer registries
experience significant reporting lag, so state
health ofﬁcials conducted active case ﬁnding to
verify leukemia occurrence. By February 2001,
the NSHD had identiﬁed 12 children who had
been diagnosed with leukemia since 1997 and
who had lived in Churchill County before their
diagnosis. The state convened an expert panel
composed of national cancer specialists, epi-
demiologists, and public health officials to
review these cases. The panel recommended
that the state epidemiologist request technical
assistance from the Centers for Disease
Control and Prevention (CDC) to investigate
whether ongoing exposure to environmental
contaminants in Churchill County might be
endangering human health (Robison et al.
2001). Two new cases were added to the state’s
list shortly after the expert panel report was
completed, bringing the number of cases
included in the state’s investigation to 14.
Multiagency response. The NSHD
responded to recommendations of the expert
panel by approaching the CDC for assistance
in Churchill County. Beginning in March
2001 the CDC led a multiagency effort to
conduct a comprehensive cross-sectional expo-
sure assessment. In Table 1 we list the state
and federal agencies that were involved and
identify the responsibilities of each agency. All
involved agencies were represented at commu-
nity meetings held throughout the study
period to provide updates on the status of the
study. During the course of the investigation,
all biologic and environmental laboratory
results were reviewed as they were received
and were collectively assessed for risk by mul-
tidisciplinary expert panels (CDC 2004); this
joint review was conducted to fulfill the
CDC’s promise to the community that any
results suggesting the possibility of an ongoing
health risk, regardless of known signiﬁcance to
the cluster analysis, would be released to the
community immediately rather than waiting
until the end of the study.
Materials and Methods
Case definition and selection of comparison
families. We deﬁned a case family as the child
diagnosed with leukemia and all other people
currently living in the child’s home (i.e., all
siblings, parents, guardians, and other adults),
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BACKGROUND. Sixteen children diagnosed with acute leukemia between 1997 and 2002 lived in
Churchill County, Nevada, at the time of or before their illness. Considering the county population
and statewide cancer rate, fewer than two cases would be expected.
OBJECTIVES. In March 2001, the Centers for Disease Control and Prevention led federal, state, and
local agencies in a cross-sectional, case-comparison study to determine if ongoing environmental
exposures posed a health risk to residents and to compare levels of contaminants in environmental
and biologic samples collected from participating families.
METHODS. Surveys with more than 500 variables were administered to 205 people in 69 families.
Blood, urine, and cheek cell samples were collected and analyzed for 139 chemicals, eight viral
markers, and several genetic polymorphisms. Air, water, soil, and dust samples were collected from
almost 80 homes to measure more than 200 chemicals.
RESULTS. The scope of this cancer cluster investigation exceeded any previous study of pediatric
leukemia. Nonetheless, no exposure consistent with leukemia risk was identiﬁed. Overall, tungsten
and arsenic levels in urine and water samples were signiﬁcantly higher than national comparison
values; however, levels were similar among case and comparison groups. 
CONCLUSIONS. Although the cases in this cancer cluster may in fact have a common etiology, their
small number and the length of time between diagnosis and our exposure assessment lessen the
ability to ﬁnd an association between leukemia and environmental exposures. Given the limitations
of individual cancer cluster investigations, it may prove more efﬁcient to pool laboratory and ques-
tionnaire data from similar leukemia clusters. 
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sten. Environ Health Perspect 115:151–157 (2007). doi:10.1289/ehp.9022 available via
http://dx.doi.org/ [Online 30 November 2006]as well as biologic parents who were not living
full time in the case child’s home and for
whom contact information was available. At
the time the CDC study was initiated, 14 case
children had already been identified by
NSHD. All 14 of the families of these chil-
dren were approached for inclusion in the
CDC study; 13 of these families agreed to
participate. One of the case children from
these families died before our study began. A
15th child was diagnosed and enrolled in the
CDC study in December 2001. A 16th child
was diagnosed after 31 December 2001, the
end of the study enrollment period. In all,
15 case families were eligible to participate,
and 14 were enrolled in the study. In Figure 1
we describe the date of diagnosis and
leukemia cell type for all 16 children diag-
nosed with leukemia. Of the 16 cases, 10
(62.5%) were residents of Churchill County
at the time of diagnosis.
Because leukemia etiology (e.g., genetic
predisposition, prenatal exposure, postnatal
exposure) may be related to age at diagnosis,
leukemia type [ALL, acute myelocytic
leukemia (AML)], cell type (B-cell, T-cell), or
geographic location, we constructed a stricter
case deﬁnition based on age (0–6 years at time
of diagnosis), diagnosis (ALL pre-B), and dura-
tion of residence in Churchill County (at least
6 months before diagnosis). Nine children met
the restricted case deﬁnition (Figure 1).
Comparison families from Churchill
County were identiﬁed through random-digit
dialing. Fifty-ﬁve (43.6%) of the 126 compari-
son families identiﬁed as eligible were enrolled.
We attempted to match four comparison chil-
dren to each case child by birth year (in 2-year
increments) and sex. The comparison child
was required to be cancer free at the date of the
case child’s leukemia diagnosis. We deﬁned a
comparison family as the matched comparison
child and that child’s parents, guardians, or
other care-taking adults living full time in the
comparison child’s home.
A total of 205 participants representing 14
(of the 15 eligible) case families and 55 com-
parison families were enrolled and asked to
complete mailed questionnaires, participate in
personal interviews, donate biologic samples,
open their homes to environmental sampling,
and provide information about previous local
residences that could be sampled. We enrolled
4 comparison families matched to the case
family that declined participation; these data
were included in the cross-sectional analysis
but not in the case-comparison analysis. Some
members of one enrolled case family chose not
to participate; the information from that case
family is included in the case-comparison
analysis. The study described here complies
with all applicable requirements of the U.S.
regulations including institutional review
board (IRB) approval. All participants signed
consent or assent forms that had been
approved as part of the IRB review of the pro-
tocol for this study (CDC 2003a).
Biologic samples. Beginning in August
2001, all participants were invited to visit a
CDC clinic in Fallon, where blood, urine, and
cheek swab samples were collected in a highly
controlled setting (CDC 2003b) and personal
interviews were administered. The biologic
samples were aliquoted on site in a biological
safety cabinet to maintain sample integrity and
to keep the samples free from chemical conta-
mination and infectious agents. These samples
were sent daily to CDC laboratories in Atlanta,
Georgia, where they were analyzed for essential
and toxic metals (CDC 2003b), nonpersistent
pesticides (Baker et al. 2004; Bravo et al. 2002;
Olsson et al. 2004), persistent pesticides and
polychlorinated biphenyls (PCBs) (Barr et al.
2003), VOCs (Cardinali et al. 2000), and
markers of past exposure to infectious diseases.
Concentrations less than the limit of detection
(LOD) were assigned a value equal to the
LOD divided by the square root of 2.
We considered both creatinine-corrected
and non-creatinine-corrected results for analy-
ses of urine samples and lipid-adjusted and
non-lipid-adjusted results for analyses of blood
samples. In this article we present non-
creatinine-corrected results for metal and non-
persistent pesticide levels in urine samples
because creatinine correction may not be reli-
able in children (Barr et al. 2005; O’Rourke
et al. 2000) and because non-creatinine-cor-
rected comparison values for most analytes
were available in the second National Report
on Human Exposure to Environmental
Chemicals (second NER) (CDC 2003d). We
present lipid-adjusted results for persistent
pesticide and PCB levels in serum samples,
and results not adjusted for lipids for VOCs
analyzed in blood samples.
Environmental samples. Using standardized
protocols (CDC/Nevada Department of
Environmental Protection 2005), the Nevada
Department of Environmental Protection col-
lected samples of indoor air, play yard soil, and
household dust from case families’ current and
previous residences in Churchill County, cur-
rent residences of all comparison families, and
previous residences for one randomly selected
comparison child for each case child. Tap water
samples from all of these residences were col-
lected by the U.S. Geological Survey (USGS).
Environmental samples were successfully col-
lected from all 11 homes of the case families
currently living in Churchill County, all 8 pre-
vious homes in Churchill County in which case
families had lived before the date of birth of the
case child (i.e., during pregnancy), current
homes of all 55 comparison families, and 6 pre-
vious residences of 15 comparison families. Of
36 previous residences eligible for sampling,
8 case homes and 14 comparison homes were
Rubin et al.
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Table 1. Agencies that assumed primary roles in the cross-sectional exposure assessment of environmen-
tal contaminants in Churchill County, Nevada, 2001–2003, including the responsibilities of each agency.
City of 
NSHD CDC/ATSDR NDEP NDOA USGS NAS-Fallon Fallon, Mayor
Study design 
Environmental samples 
Collection   
Analysis 
Biologic samples 
Collection  
Analysis 
Results interpretation    
Community meeting     
Abbreviations: NDEP, Nevada Division of Environmental Protection; NDOA, Nevada Department of Agriculture.
Figure 1. Temporal distribution of the 16 children who had lived in Churchill County, Nevada, and were
diagnosed with leukemia between June 1997 and August 2002. Cancer type and cell type are deﬁned. One
case declined participation in the study, and one was diagnosed outside the study period. The nine indi-
viduals ﬁtting the restricted case deﬁnition are indicated by asterisks (*).
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*not accessible (e.g., house was destroyed or
vacant, or current owner was nonresponsive).
Current and previous residences outside
of Churchill County were not sampled.
Household samples were tested for heavy met-
als, persistent and nonpersistent pesticides,
PCBs, VOCs, radon, and radionuclides.
Environmental samples were analyzed by the
USGS, U.S. EPA Region 9, the Nevada
Department of Agriculture, and several contract
laboratories. In this article we present results of
environmental sample analysis only when they
are relevant to biologic sample results.
Statistical analysis. In our primary analysis,
we used univariate statistics to describe each of
the exposures analyzed. For continuous vari-
ables, we used geometric means and selected
percentiles to summarize the range and distrib-
ution of the data for the various subpopula-
tions of interest. We calculated geometric
means [with 95% conﬁdence intervals (CIs)]
assuming that the data approximated a log-
normal distribution, and only when the pro-
portion of results above the LOD was at least
60%. The estimates of the mean and 95% CI
are based on a statistical model that controlled
for the possible correlation of observations
within a family (i.e., a variance components
model), when appropriate. Categorical vari-
ables, frequency counts, and percentages are
presented as summary statistics for the subpop-
ulations of interest. In the secondary analysis,
we compared exposure among the case and
comparison populations using conditional
logistic regression; we initially analyzed all cases
and their corresponding controls, and then
only those cases and their corresponding con-
trols meeting the restricted case deﬁnition.
For categorical exposure variables, odds
ratios (ORs) are used to assess the association
between disease and exposure between two
speciﬁc levels of the categorical variable. For
continuous exposure variables, the ORs are
based on data that were standardized before
analysis. The exposure measures were stan-
dardized by dividing each individual response
by the standard deviation observed among the
entire study population. Because of the lim-
ited sample size, ORs were not adjusted for
potential confounders. The LogXact software
from Cytel Corporation (version 4.0; Cytel
Software Corp., Cambridge, MA) was used to
ﬁt the conditional logistic regression models.
For this investigation, many of the logistic
regression models compared current levels of
exposure among the case and comparison pop-
ulations. Because both populations were sam-
pled after diagnosis of leukemia among the
case population, treatment, past diagnostic
procedures, changes in behavior, and changes
in chemical exposures over time may all have
signiﬁcant, although immeasurable, impact on
the relationships that were explored in our
secondary analysis.
Tungsten follow-up. When preliminary
study results suggested unusually high levels of
tungsten in urine and water samples collected
from Churchill County, we decided to expand
our study to include tungsten measurements in
three other Nevada communities to determine
if the findings in Churchill County were
unique or represented levels characteristic of
the region. The towns of Lovelock, Yerington,
and Pahrump were chosen for a cross-sectional
tungsten exposure based on hydrogeologic cri-
teria and history of tungsten mining (CDC
2003c). A geographically random sample pool
was selected in each town, including 30 house-
holds each from Yerington and Pahrump and
11 households from Lovelock. For sample
selection, coordinate grids were superimposed
over maps of a given city. A random list of X
and Y grid coordinates was generated; the ﬁrst
30 coordinates falling within the city limits
were selected, and the household closest to each
coordinate was approached for recruitment. If
the ﬁrst house refused participation or was ineli-
gible, the next closest house was approached.
The eligibility criteria for households are resi-
dence in the city for at least 1 month before the
interview and the presence of one adult and one
child younger than 18 years who consent to
participate in the study. Eligibility criteria
included residence for at least 1 month before
the interview. Environmental sampling
included tap water, floor dust, and yard soil
from each household. Urine samples were col-
lected from one adult and one child younger
than 18 years in each family. A total of 141 par-
ticipants were recruited, ranging in age from
2 to 65 years (children younger than 18 aver-
aged 9.4 years of age and adults averaged
38.9 years of age). Sample collection procedures
and their analytical parameters were identical to
those used to measure tungsten in the Churchill
County study.
Results
Data collected in Churchill County included
responses to 500 questionnaire items, levels of
139 chemicals, and eight viral markers meas-
ured in blood and urine samples, including
genetic analysis of DNA specimens from whole
blood collected from 205 people in 69 families.
Levels of more than 200 chemicals were meas-
ured in air, water, soil, or dust from almost
80 homes. Among our 69 study children
(14 case and 55 comparison), 34 were female
and 61 were white. There were no signiﬁcant
differences in proportions of sex, race, and eth-
nicity between case and comparison children.
Our primary analysis was a cross-sectional
study that included biologic measurements.
Our secondary analysis compared question-
naire information, biologic values, and
environmental findings between case and
comparison children and families. We recog-
nized that the primary and secondary analyses
of hundreds of questionnaire and laboratory
data points would, by sheer probability, result
in some statistically signiﬁcant ﬁndings due to
chance occurrence. Therefore, we reviewed all
results in terms of biological plausibility and
also rigorously sought the opinions of panels
of experts who reviewed the results of the
many data outcomes. Enrolled case children
(7 girls and 7 boys) ranged in age from 2 to
19 years at diagnosis; case and matched com-
parison children (27 girls and 28 boys) ranged
in age from 3 to 20 years at time of sample
collection. In this article we present results
relating to a) one environmental contaminant
found to be unusually elevated and therefore a
potential and ongoing health risk (i.e., tung-
sten); b) lifestyle and demographic factors
(e.g., birth weight, breast-feeding) associated
with leukemia or exposures to known or sus-
pected carcinogens (e.g., VOCs, arsenic, ioniz-
ing radiation, pesticides); and c) ﬁndings that
were statistically signiﬁcant (e.g., parental age)
or of community interest (e.g., military sta-
tus). Complete results are available at http://
www.cdc.gov/nceh/clusters/Fallon (CDC
2004), and genetic results will be presented
elsewhere (Steinberg et al. 2006).
Tungsten. The median tungsten level
found in urine samples from the entire study
population was 0.97 µg/L (geometric mean,
1.19 µg/L), compared with 0.07 µg/L (geo-
metric mean, 0.08 µg/L) in the 1999
National Health and Nutrition Examination
Survey (NHANES), the most current popula-
tion reference available in August 2002 or in
the second NER (CDC 2003d). In our sec-
ondary analysis, median levels were similar for
case and comparison children (1.93 and
2.35 µg/L) and case and comparison families
(0.61 and 0.62 µg/L). Almost 80% of the
Churchill County participants had tungsten
levels above the 95th percentile (0.48 µg/L)
reported in the second NER. The level of
exposure to tungsten that may cause health
effects is not known. The CDC successfully
petitioned the National Toxicology Program
of the National Institute of Environmental
Health Sciences, National Institutes of
Health, to prioritize research regarding the
health effects of tungsten exposure. The CDC
contracted with USGS to collect and measure
tungsten in tap water samples from partici-
pants’ homes. Results ranged from < LOD to
290 µg/L. There is no regulatory limit for
tungsten in drinking water.
In the three additional Nevada communi-
ties that were sampled for tungsten, 68% of
the participants had geometric mean levels of
urinary tungsten at or above the 95th
percentile second NER levels (Table 2).
Yerington, the town most similar to Churchill
County with respect to hydrology, geology,
and land use, had levels of tungsten in urine
and water samples that were statistically similar
Cancer cluster in Churchill County, Nevada
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hold soil and dust samples from the three
comparison communities yielded detectable
tungsten levels; however, the method used
had a high LOD (50 µg/g).
Arsenic. In our cross-sectional analysis,
arsenic levels in urine ranged from < LOD to
1,180 µg/L, with a geometric mean of
34.6 µg/L and median of 37.4 µg/L. A
national reference value for urinary arsenic lev-
els is currently unavailable. However, a study
of arsenic exposure in Washington State
showed urinary arsenic levels ranging from
19.6 µg/L (associated with high exposure) to
9.4 µg/L (associated with low exposure)
(Kalman et al. 1990). Furthermore, the 95th
percentile for nonrandom samples of the U.S.
population is 22 µg/L (CDC, unpublished
data). Noncarcinogenic clinical effects are
observed at urinary concentrations > 200 µg/L
(Hall 1998); however, clinical effects from
concentrations < 200 µg/L may be possible.
Although not a statistically signiﬁcant ﬁnding,
levels of arsenic were nominally higher (p =
0.25) in children (geometric mean, 38.9 µg/L)
than in their parents (geometric mean,
32.3 µg/L). In our secondary analysis, arsenic
levels did not differ significantly (p = 0.29)
between case children (geometric mean,
29.8 µg/L) and comparison children (geomet-
ric mean, 41.3 µg/L) or between case families
(geometric mean, 23.9 µg/L) and comparison
families (geometric mean, 36.0 µg/L) (p =
0.18). Arsenic was also measured in tap water
samples collected from 70 current and previous
residences. Overall results ranged from < LOD
to 874 µg/L (median, 50.9 µg/L). At the time
of this study, the U.S. EPA regulatory limit for
arsenic in municipal drinking water systems
was 50 µg/L; as of 1 January 2006, the regula-
tory limit is 10 µg/L.
Known or suspected risk factors. Biologically
plausible environmental risk factors of concern
in Churchill County included exposure to ben-
zene and other VOCs from JP-8 fuel and also
exposure to persistent and nonpersistent pesti-
cides. We analyzed other lifestyle and demo-
graphic risk factors that have been implicated in
the development of leukemia, including expo-
sure to ionizing radiation (Doll 1995; Miller
1967; Preston et al. 1994), parental age at
child’s birth (Dockerty et al. 2001), birth
weight (Hjalgrim et al. 2004; Robison et al.
1987), breast-feeding (Kwan et al. 2004), his-
tory of allergies (Schuz et al. 1999; Wen et al.
2000a), and parental military service (CDC
1988; Wen et al. 2000b).
VOCs. We analyzed blood samples for
12 VOCs, including benzene, which is a minor
component of JP-8 fuel and gasoline. Most
study participants had blood benzene levels
below method LODs (0.06 ng/mL). Median
VOC levels in Churchill County were similar
to those reported in NHANES III (Churchill
et al. 2001) and other peer-reviewed reference
levels (Table 3). Levels of 2,5-dimethylfuran
among the study population were consistent
with levels reported in the literature (Ashley
et al. 1996) for smokers and nonsmokers. In
the Churchill County population, smokers had
a median level of 0.08 µg/L and nonsmokers
had a median level below the LOD (= 0.024).
In our secondary analysis, 7 VOCs were
detectable in a high enough percentage of sam-
ples to calculate ORs. Exposure to ethyl-
benzene suggested increased risk for leukemia
among case children using the broader case
deﬁnition (OR 2.67; 95% CI, 1.04–6.84) as
well as the restricted case deﬁnition (OR 6.13;
95% CI, 1.29–29.00). When comparing case
and control families using the broad deﬁnition
of a case, we found a slightly positive, although
not statistically signiﬁcant, association between
leukemia status and exposure to ethylbenzene
(OR 1.14; 95% CI, 0.73–1.78). This OR was
somewhat lower and still not statistically signif-
icant when we analyzed levels of ethylbenzene
among case and control families using the
restricted case deﬁnition (OR 1.08; 95% CI,
0.60–1.94).
Tetrachloroethylene was the only VOC
that showed a slightly significant protective
OR (0.35; 95% CI, 0.14–0.86) between case
and comparison families (including case and
comparison children and their family members
but excluding siblings). When comparing case
and comparison children, however, we
detected no statistical differences in VOC
levels using either the broad case definition
(OR 0.32; 95% CI, 0.05–2.14) or the
restricted case deﬁnition (OR 0.39; 95% CI,
0.04–3.91).
Pesticides. Geometric mean levels of 5 of
the 31 nonpersistent pesticides that we meas-
ured in urine samples were above the reference
geometric mean (Table 4); 5 of the pesticides
were well below the national reference values,
and the rest were very similar to reference lev-
els. In our secondary analysis, none of the non-
persistent pesticides were associated with
leukemia risk.
Of the 11 persistent pesticides measured in
serum samples, only dichlorodiphenyldichloro-
ethylene [DDE; a breakdown product of
dichlorodiphenyltrichloroethane (DDT)] was
elevated in our study population (median,
445.3 ng/g lipid; geometric mean, 447.1;
range, < LOD to 8169.95) when compared
with the second NER (median, 226.0 ng/g
lipid; geometric mean, 260). However, when
we analyzed DDE levels stratified by birth-
place, we found that the elevation persisted
only among parents born outside the United
States and among children breast-fed by moth-
ers born outside the United States (Figure 2).
In the secondary analysis, we found no rela-
tionship between leukemia status and exposure
to any of the persistent pesticides.
Lifestyle and demographic factors.
Ionizing radiation. We used data collected
via questionnaire to analyze exposure to ioniz-
ing radiation related to medical procedures.
Rubin et al.
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Table 2. Geometric mean tungsten levels for urine and water samples in multiple Nevada communities.
Geometric mean tungsten level [µg/L (95% CI)]
Urinea
Location Adults Children Total Tap water
Lovelock 0.38 (0.33–0.45) 0.62 (0.50–0.76) 0.48 (0.34–0.68) 0.11 (0.07–0.19)
Pahrump 0.4 (0.38–0.53) 0.56 (0.48 – 0.66) 0.51 (0.37–0.69) 0.04 (0.02–0.06)
Yerington 1.04 (0.84–1.30) 1.18 (1.00–1.39) 1.11 (0.97–1.27) 3.32 (1.82–6.04)
Churchill County 0.81 (0.56–1.16) 2.31 (1.66–3.22) 1.19 (0.89–1.59) 4.66 (2.98–7.30)
aThe geometric mean urine tungsten level for the NHANES national reference population (reported in the second NER) is
0.08 µg/L (0.07–0.09) (CDC 2003c).
Table 3. VOCs (µg/L) in the blood of people living in the United States and people living in Churchill County,
Nevada.
United States Churchill County
Median levels  Median levels of  Percent > U.S. 
VOCs from NHANES IIIa 95th percentile total study population 95th percentile
1,1,1-Trichloroethane 0.13 0.8 NC 0.0
1,4-Dichlorobenzene 0.33 9.2 0.08 0.0
Benzene 0.061 0.48 0.07 1.0
Carbon tetrachloride NCb NC NC NC
Ethylbenzene 0.060 0.25 0.05 2.0
m-/p-Xylene 0.19 0.78 0.26 2.0
o-Xylene 0.10 0.28 0.06 2.0
Styrene 0.041 0.18 0.05 8.0
Tetrachloroethylene 0.063 0.62 0.04 4.0
Toluene 0.28 1.5 0.2 1.0
Trichloroethene < LOD 0.021 NC 5.0
NC, not calculated.
aFrom Churchill et al. (2001). VOCs were not reported in the second NER (CDC 2003d). bLess than 60% of the study popula-
tion had detectable levels of this chemical.We asked whether the study child’s mother
received an X ray or other type of radiologic
scan, excluding dental X rays, during her
pregnancy with the study child. We also
asked whether study children were exposed to
these same types of radiation before diagnosis
for case children and before 30 June 2001 for
comparison children. Three mothers (4.7%)
reported having an X ray or radiologic scan
during pregnancy with the study child; this
exposure suggested a nonsignificant associa-
tion for both broad and restricted case deﬁni-
tion analyses (OR 3.46; 95% CI, 0.04–
274.70). Forty-one children (60.3%) were
reported to have had an X ray or radiologic
scan before the date of interest. There was no
difference in exposure to ionizing radiation
among either the broad (OR 0.65; 95% CI,
0.17–2.41) or restricted (OR 0.19; 95% CI,
0.02–1.17) case deﬁnition populations.
Parental age. Overall median paternal age
at time of birth for our study population was
29 years (range, 16–45 years; mean,
29.2 years). The median age of fathers at the
time of birth of case children was 33 years and
of comparison children was 28 years. Median
maternal age at time of birth for the study pop-
ulation was 26 years (range, 15–37 years;
mean, 26.3 years). The median maternal age at
time of birth of case children was 28 years and
of comparison children was 26 years. Using
conditional logistic regression to evaluate dif-
ferences between case and comparison paternal
age, we found an association between leukemia
diagnosis and fathers being older at the time of
the study child’s birth when age was used as a
continuous variable (OR 1.14; 95% CI,
1.01–1.29). This parental age difference per-
sisted for the restricted case deﬁnition group
(OR 1.19; 95% CI, 1.02–1.39). When we
analyzed paternal age as a discrete variable
(> 40 vs. < 40 years of age) the association was
not statistically signiﬁcant (OR 3.94; 95% CI,
0.25–62.5). We found no association between
case status and maternal age.
Birth weight, duration of breast-feeding,
and immune status. We looked at question-
naire information regarding birth weight,
breast-feeding, and physician diagnosis of
allergies because the literature has suggested a
possible association between these risk factors
and leukemia (Belson et al. 2006; Bufﬂer et al.
2005; Sandler and Ross 1997). Median birth
weight for all study children was 3,390 g;
median for case children was 3,487 g, and
3,359 g for comparison children. We found a
nonsigniﬁcant (p = 0.27) association (OR 1.73;
95% CI, 0.39–8.14) among children with
birth weight > 3,500 g (8 pounds). We found a
nonsignificant association (p = 0.96) among
children who were ever breast-fed (OR 1.35;
95% CI, 0.29–8.50). However, no association
was seen when duration of breast-feeding was
used as a continuous variable (OR 1.00; 95%
CI, 0.99–1.01). Case children were less likely
than controls ever to have been diagnosed by a
physician with an allergic skin rash (OR 0.067;
95% CI, 0–0.46), although this estimate is
considered unstable because no case children
answered yes to the question.
Military service. Nineteen children (6 case
and 13 comparison children) had at least one
parent who was serving in the military at some
point between 1 year before the child’s birth
and the case child’s date of diagnosis. Military
service during this time period, however, was
not statistically associated with leukemia
(OR 3.58; 95% CI, 0.72–20.25). When we
restricted our analysis to parents who were in
the military during 1 year before the child’s
birth (6 case and 10 comparison children),
and excluded three comparison children who
were adopted, we still found a nonsigniﬁcant
association between leukemia and military ser-
vice (OR 5.05; 95% CI, 0.96–29.78). We
found no particular patterns in jobs held while
in military service. Case parents reported job
descriptions including construction, clerical,
fighter pilot, hydraulic mechanic, aircraft
maintenance, and dentistry.
Discussion
In this study we examined ongoing environ-
mental exposures by collecting and analyzing
biologic and environmental samples at a level
of detail not previously attempted or achieved
in any other cancer cluster investigation.
Nonetheless, no exposure consistent with
leukemia risk was identified. We found that
tungsten and arsenic were elevated in biologic
and environmental samples when compared
with samples from other populations, regula-
tory levels, or health-based recommendations,
and we subsequently recommended personal
and community actions for reducing exposure.
We did not ﬁnd an association between arsenic
or tungsten exposure and leukemia, however.
Furthermore, exposure to tungsten in Churchill
County does not appear to be unique when
compared with certain other similar communi-
ties in Nevada. Our studies indicated that peo-
ple living in communities having water sources
and geologic formations similar to those in
Churchill County may be expected to have
tungsten exposures well above those reported as
national reference levels. Moreover, the NSHD
has not identiﬁed any excess leukemia in the
three additional communities studied. The
National Toxicology Program is currently
evaluating the carcinogenicity of tungsten
(National Toxicology Program 2003).
Churchill County residents were aware that
their water contained high levels of arsenic, but
most participants reported personal historical
and ongoing behaviors (e.g., drinking only bot-
tled water, installing point-of-use treatment)
intended to decrease their exposure. Most par-
ticipants were surprised by their elevated bio-
logical arsenic levels. The city of Fallon and
NAS completed construction on a new water
treatment facility in April 2004 that should fur-
ther reduce arsenic levels in tap water.
Our finding of an elevated OR (5.05;
95% CI, 0.96–29.78) for parental military
service, albeit not statistically significant, is
suspect given that the six military case parents
reported such disparate job descriptions.
Further, a recent publication found no gen-
eral increase in childhood leukemia in other
U.S. counties with military bases (Steinmaus
et al. 2004). Spurious findings are to be
expected in any study, such as this one, that
makes thousands of comparisons (Rothman
1990; Wartenberg and Greenberg 1992).
Military personnel experience more frequent
geographic relocations than most U.S. fami-
lies, but a single cluster investigation cannot
evaluate the impact of population mixing
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Table 4. Geometric means and 95th percentile levels in a U.S. reference population of nonpersistent pesti-
cides that were detected in urine samples of > 60% of a study population in Churchill County, Nevada, and
the geometric mean levels and percent of the Churchill County study population with levels above the U.S.
95th percentile.
United States Churchill County
Nonpersistent pesticide  Geometric mean  95th percentile Geometric mean  Percent > U.S. 
or metabolite [µg/La (95% CI)] (95% CI) [µg/L (95% CI)] 95th percentile
Chlorpyrifos 1.77 (1.56–2.01) 9.90 (7.60–14.0) 2.46 (1.93–3.14) 16.3
Diethylthiophosphate NCb 2.20 (1.70–2.80) 1.04 (0.81–1.33) 29.5
2,4-Dichlorophenol 1.11 (0.88–1.40) 22.0 (17.0–31.0) 1.15 (0.91–1.46) 0.5
2,4,5-Trichlorophenol NC 16.0 (4.30–39.0) 4.48 (3.64–5.53) 20.3
2-Naphthol 0.47 (0.33–0.68) 15.0 (9.90–19.3) 0.98 (0.73–1.32) 8.4
NC, not calculated. 
aUrine levels are not creatinine adjusted. bLess than 60% of the study population had detectable levels of this chemical.
Figure 2. DDE levels measured in blood samples
from 52 mothers and 56 children in Churchill
County, Nevada, stratified by birth location of
mother. Dashed line represents the U.S. mean level
of DDE (226 ng/g lipid) (CDC 2003d).
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n = 50theory on leukemia incidence (Kinlen et al.
1990; Kinlen and Stiller 1993). Our results
should be included in research that combines
data from several cluster investigations.
Deﬁning a case. AML and ALL are widely
recognized as biologically different diseases and
are therefore likely to have different etiologies
(Kersey 1997). Moreover, even subgroups of
ALL, or widely discrepant age groups within a
cell-type subgroup, may manifest different
treatment responses and disease outcomes
(Greaves 2002). Our study may be limited
because we included a variety of leukemia types
in some parts of our analysis. Similarly, some
parts of our analysis are possibly skewed by
inclusion of case children who had only
recently moved to Churchill County, had been
tangentially exposed to the Churchill County
environment, or had moved away from
Churchill County long before their diagnosis.
To overcome these limitations, we conducted
separate statistical analyses on a restricted num-
ber of cases that appeared to be most alike.
Although these subanalyses did not yield
meaningful results, we encourage researchers to
combine data from this and future leukemia
studies to obtain a larger sample size of cases
meeting the strict case deﬁnition. Other limita-
tions, particularly of the secondary analyses in
which we compared case with comparison sub-
jects, reﬂect the issue of temporality and our
limited ability to control confounding factors.
Cancer clusters can occur by chance.
However, the statistical process of fully evalu-
ating the role of chance in a suspected cluster
occurrence is daunting and lacks standardiza-
tion, leaving political and emotional pressures
to drive cluster investigations. Ideally, a cancer
cluster should be evaluated not just on
whether it exceeds previous cancer incidence
in a speciﬁc deﬁned geographical area during a
specific time frame but whether it exceeds
expected cancer incidence after accounting for
the many ways to define “area,” the large
number of areas, as well as the many ways that
one could choose a time period for evaluation
(Wartenberg 2001).
The importance of peer review. Cancer
cluster investigations are highly charged with
emotional and political overtones that
inevitably challenge the validity of results
(Aldrich and Sinks 2002; Neutra 1990;
Rothman 1990; Thun and Sinks 2004;
Wartenberg 1995). Affected families and com-
munities are frustrated by a lack of conclusive
findings, whereas public health investigators
are equally frustrated by their inability to iden-
tify a causative agent. In an attempt to mitigate
these frustrations, we convened several external
peer-review and community-based panels to
review and deliberate on our results. This
ongoing peer review enhanced communication
and increased our conﬁdence in the methods
and conclusions of this study.
Conclusions
This large scale, costly, multiagency response
in Churchill County was mounted because this
cancer cluster greatly exceeded chance expecta-
tion. The families of the 14 case children ini-
tially included in the state investigation, plus
the two subsequently diagnosed cases, made
Churchill County one of the largest pediatric
leukemia clusters in U.S. history. Even if one
limits the case count to include only children
with pre–B-cell ALL who were living in
Churchill County at time of diagnosis and for
at least 6 months before diagnosis, the number
of Churchill County children with this disease
is extraordinary.
This cluster occurred at a time when newly
advanced laboratory methods enabled quantiﬁ-
cation of environmental contaminants in bio-
logic and environmental samples at levels not
previously possible. Nonetheless, the inability
of modern science to identify the role of envi-
ronmental exposures in leukemia incidence
reﬂects the complexity of deﬁning a relation-
ship between exposure and cancer in a commu-
nity setting. Biologic samples from Churchill
County participants are being stored and will
be used by investigators, along with samples
from other ALL clusters, to look for emerging
environmental carcinogens. Future analyses
that combine questionnaire information as well
as banked biological data from a series of ALL
clusters may yield results that could not be
obtained in the Churchill County investigation.
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